Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2021

View Archived Issues

Uncovering the roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair

ARID1A is a marker of endometriosis progression

BUD13 identified as candidate gene in specific language impairment

Targeting GSDMD-mediated pyroptosis as therapeutic strategy for endometriosis

Fujifilm patents HDAC6 inhibitors

Merck & Co. divulges new coagulation factor XIa inhibitors

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Enyo Pharma presents ICD inducers

Researchers identify new GPR52 agonists

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

SLFN11 predicts treatment response to TAS-1553 in AML

Purnovate selects PNV-5030 as lead compound in pain program

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...